交易 Cabaletta Bio, Inc. - CABA CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.0812 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Cabaletta Bio Inc ESG Risk Ratings
High Medium Low Negligible
“D”分數表示相對 ESG 表現較差,公開報告重要 ESG 數據的透明度不足。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Mar 28, 2024 | 16.9894 | 0.0200 | 0.12% | 16.9694 | 17.4394 | 16.7794 |
Mar 27, 2024 | 17.0894 | 0.0900 | 0.53% | 16.9994 | 17.1094 | 16.5694 |
Mar 26, 2024 | 16.8994 | 0.0500 | 0.30% | 16.8494 | 17.0894 | 16.5794 |
Mar 25, 2024 | 16.7394 | -0.7000 | -4.01% | 17.4394 | 17.8394 | 16.6294 |
Mar 22, 2024 | 17.2994 | 0.4800 | 2.85% | 16.8194 | 18.3794 | 16.8094 |
Mar 21, 2024 | 17.4894 | -0.4800 | -2.67% | 17.9694 | 18.0594 | 16.2794 |
Mar 20, 2024 | 18.0794 | 0.3100 | 1.74% | 17.7694 | 18.1794 | 17.2494 |
Mar 19, 2024 | 17.9594 | 0.6400 | 3.70% | 17.3194 | 18.6694 | 17.3194 |
Mar 18, 2024 | 17.9594 | -0.4600 | -2.50% | 18.4194 | 18.5794 | 17.1694 |
Mar 15, 2024 | 18.7094 | 0.2300 | 1.24% | 18.4794 | 19.4794 | 18.1294 |
Mar 14, 2024 | 18.9094 | -0.9700 | -4.88% | 19.8794 | 20.1794 | 18.7294 |
Mar 13, 2024 | 20.2094 | -0.4900 | -2.37% | 20.6994 | 21.1194 | 19.8794 |
Mar 12, 2024 | 20.6594 | 0.3600 | 1.77% | 20.2994 | 20.8594 | 19.7894 |
Mar 11, 2024 | 20.3394 | -1.8800 | -8.46% | 22.2194 | 22.4494 | 20.2594 |
Mar 8, 2024 | 22.4294 | -0.1600 | -0.71% | 22.5894 | 23.0394 | 21.7794 |
Mar 7, 2024 | 22.2794 | 0.2000 | 0.91% | 22.0794 | 23.1094 | 22.0394 |
Mar 6, 2024 | 22.5294 | 0.4600 | 2.08% | 22.0694 | 22.5794 | 21.5494 |
Mar 5, 2024 | 21.5894 | -0.3400 | -1.55% | 21.9294 | 22.4994 | 21.0194 |
Mar 4, 2024 | 21.9194 | -1.7200 | -7.28% | 23.6394 | 23.6494 | 21.5794 |
Mar 1, 2024 | 23.9194 | 1.0600 | 4.64% | 22.8594 | 24.6194 | 22.8594 |
Cabaletta Bio, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Thursday, May 9, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q1 2024 Cabaletta Bio Inc Earnings Release Q1 2024 Cabaletta Bio Inc Earnings ReleaseForecast(預報) -返回 - |
Friday, May 31, 2024 | ||
時間 (UTC) 13:00 | 國家 US
| 事件 Cabaletta Bio Inc Annual Shareholders Meeting Cabaletta Bio Inc Annual Shareholders MeetingForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 54.139 | 46.313 | 33.833 | 18.683 | 6.193 |
銷售/一般/行政費用,總計 | 14.839 | 13.819 | 12.457 | 7.012 | 1.726 |
研究與開發 | 39.3 | 32.494 | 21.376 | 11.671 | 4.467 |
營業收入 | -54.139 | -46.313 | -33.833 | -18.683 | -6.193 |
利息收入(費用),非經營淨值 | 1.164 | 0.024 | 0.494 | 1.74 | 0.235 |
其他,淨值 | 0 | -6.244 | |||
稅前淨收入 | -52.975 | -46.289 | -33.339 | -16.943 | -12.202 |
稅後淨收入 | -52.975 | -46.289 | -33.339 | -16.943 | -12.202 |
未計算非常項目前的淨收益 | -52.975 | -46.289 | -33.339 | -16.943 | -12.202 |
淨收入 | -52.975 | -46.289 | -33.339 | -16.943 | -12.202 |
普通股股東可獲收益 (不含非經常性項目) | -52.975 | -46.289 | -33.339 | -22.269 | -12.202 |
普通股股東可獲收益 (含非經常性項目) | -52.975 | -46.289 | -33.339 | -22.269 | -12.202 |
攤薄淨收入 | -52.975 | -46.289 | -33.339 | -22.269 | -12.202 |
攤薄後加權平均股 | 29.3429 | 25.7373 | 23.1452 | 24.034 | 22.5529 |
扣除特別項目的每股攤薄盈利 | -1.80538 | -1.79852 | -1.44043 | -0.92656 | -0.54104 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
每股正常攤薄盈利 | -1.80538 | -1.79852 | -1.44043 | -0.92656 | -0.54104 |
Total Adjustments to Net Income | 0 | -5.326 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 15.89 | 16.956 | 16.302 | 11.778 | 13.06 |
銷售/一般/行政費用,總計 | 4.093 | 4.521 | 3.902 | 3.562 | 3.546 |
研究與開發 | 11.797 | 12.435 | 12.4 | 8.216 | 9.514 |
營業收入 | -15.89 | -16.956 | -16.302 | -11.778 | -13.06 |
利息收入(費用),非經營淨值 | 1.403 | 1.102 | 0.61 | 0.351 | 0.15 |
稅前淨收入 | -14.487 | -15.854 | -15.692 | -11.427 | -12.91 |
稅後淨收入 | -14.487 | -15.854 | -15.692 | -11.427 | -12.91 |
未計算非常項目前的淨收益 | -14.487 | -15.854 | -15.692 | -11.427 | -12.91 |
淨收入 | -14.487 | -15.854 | -15.692 | -11.427 | -12.91 |
普通股股東可獲收益 (不含非經常性項目) | -14.487 | -15.854 | -15.692 | -11.427 | -12.91 |
普通股股東可獲收益 (含非經常性項目) | -14.487 | -15.854 | -15.692 | -11.427 | -12.91 |
攤薄淨收入 | -14.487 | -15.854 | -15.692 | -11.427 | -12.91 |
攤薄後加權平均股 | 39.1728 | 35.4492 | 30.4136 | 29.014 | 28.9869 |
扣除特別項目的每股攤薄盈利 | -0.36982 | -0.44723 | -0.51595 | -0.39384 | -0.44537 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.36982 | -0.44723 | -0.51595 | -0.39384 | -0.44537 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 108.834 | 124.541 | 113.535 | 140.552 | 33.994 |
現金和短期投資 | 106.547 | 122.222 | 108.662 | 136.204 | 33.017 |
現金等價物 | 81.607 | 122.222 | 101.429 | 136.204 | 33.017 |
預付的費用 | 2.287 | 2.319 | 4.873 | 4.348 | 0.977 |
總資産 | 116.968 | 126.336 | 114.724 | 141.468 | 34.174 |
其他長期資産,總計 | 0.565 | 0.357 | 0.299 | 0.101 | 0.18 |
流動負債總額 | 9.489 | 8.38 | 5.18 | 3.147 | 0.943 |
應付賬款 | 2.463 | 2.333 | 1.243 | 0.92 | 0.603 |
預提費用 | 5.694 | 2.977 | 2.445 | 1.522 | 0.121 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 1.332 | 3.07 | 1.492 | 0.705 | 0.219 |
負債總額 | 12.448 | 8.38 | 5.18 | 3.147 | 0.943 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
股權 | 104.52 | 117.956 | 109.544 | 138.321 | 33.231 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 43.921 |
普通股 | 0.00029 | 0.00029 | 0.00024 | 0.00024 | 0 |
額外實收資本 | 270.129 | 230.543 | 175.836 | 171.28 | 1.762 |
留存收益(累計赤字) | -165.562 | -112.587 | -66.298 | -32.959 | -12.452 |
總負債和股東權益 | 116.968 | 126.336 | 114.724 | 141.468 | 34.174 |
已發行普通股總數 | 29.4451 | 28.9271 | 24.0628 | 24.034 | 22.5529 |
物業/廠房/設備,總計 - 淨額 | 7.569 | 1.438 | 0.89 | 0.815 | |
其他權益,總計 | -0.04729 | -0.00029 | 0.00576 | -0.00024 | |
短期投資 | 24.94 | 0 | 7.233 | ||
物業/廠房/設備,總計 - 總額 | 9.938 | 2.629 | 1.348 | ||
累計折舊,總計 | -2.369 | -1.191 | -0.458 | ||
其他負債,總計 | 2.959 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 166.178 | 177.572 | 95.734 | 108.834 | 88.175 |
現金和短期投資 | 164.391 | 176.328 | 93.845 | 106.547 | 85.895 |
現金等價物 | 115.501 | 128.072 | 93.845 | 81.607 | 61.163 |
短期投資 | 48.89 | 48.256 | 0 | 24.94 | 24.732 |
預付的費用 | 1.787 | 1.244 | 1.889 | 2.287 | 2.28 |
總資産 | 173.287 | 184.637 | 103.447 | 116.968 | 91.675 |
物業/廠房/設備,總計 - 淨額 | 6.125 | 6.38 | 7.132 | 7.569 | 2.811 |
其他長期資産,總計 | 0.984 | 0.685 | 0.581 | 0.565 | 0.689 |
流動負債總額 | 10.616 | 8.482 | 9.305 | 9.489 | 5.801 |
應付賬款 | 3.62 | 2.341 | 3.955 | 2.463 | 1.333 |
預提費用 | 5.632 | 4.157 | 3.176 | 5.694 | 2.268 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 1.364 | 1.984 | 2.174 | 1.332 | 2.2 |
負債總額 | 12.364 | 10.496 | 11.796 | 12.448 | 5.801 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
股權 | 160.923 | 174.141 | 91.651 | 104.52 | 85.874 |
普通股 | 0.00042 | 0.00039 | 0.00031 | 0.00029 | 0.00029 |
額外實收資本 | 373.295 | 370.047 | 273.067 | 270.129 | 235.953 |
留存收益(累計赤字) | -212.351 | -195.903 | -181.416 | -165.562 | -149.87 |
其他權益,總計 | -0.02142 | -0.00339 | -0.00031 | -0.04729 | -0.20929 |
總負債和股東權益 | 173.287 | 184.637 | 103.447 | 116.968 | 91.675 |
已發行普通股總數 | 41.6602 | 39.7937 | 31.341 | 29.4451 | 29.014 |
Redeemable Preferred Stock | 0 | 0 | 0 | 0 | |
其他負債,總計 | 1.748 | 2.014 | 2.491 | 2.959 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -52.975 | -46.289 | -33.339 | -16.943 | -12.202 |
經營活動産生的現金 | -46.38 | -34.109 | -26.77 | -16.045 | -4.661 |
非現金物品 | 9.716 | 5.866 | 4.507 | 2.3 | 8.005 |
營運資金的變化 | -4.299 | 5.581 | 1.708 | -1.506 | -0.464 |
融資活動産生的現金 | 32.982 | 48.903 | -0.024 | 119.925 | 37.677 |
股票的發行(報廢),淨額 | 32.982 | 48.903 | -0.024 | 119.925 | 37.677 |
現金淨變化 | -40.615 | 20.793 | -34.775 | 103.187 | 33.016 |
經營活動産生的現金 | 1.178 | 0.733 | 0.354 | 0.104 | |
投資活動産生的現金 | -27.217 | 5.999 | -7.981 | -0.693 | |
資本支出 | -2.453 | -1.166 | -0.635 | -0.693 | |
其他投資現金流量項目,總計 | -24.764 | 7.165 | -7.346 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -15.854 | -52.975 | -37.283 | -25.856 | -12.946 |
Cash From Operating Activities | -12.608 | -46.38 | -34.249 | -24.335 | -12.809 |
Cash From Operating Activities | 0.365 | 1.178 | 0.82 | 0.457 | 0.219 |
Non-Cash Items | 3.023 | 9.716 | 5.142 | 3.466 | 1.763 |
Changes in Working Capital | -0.142 | -4.299 | -2.928 | -2.402 | -1.845 |
Cash From Investing Activities | 24.62 | -27.217 | -26.901 | -50.809 | -49.911 |
Capital Expenditures | -0.38 | -2.453 | -2.137 | -1.045 | -0.147 |
Other Investing Cash Flow Items, Total | 25 | -24.764 | -24.764 | -49.764 | -49.764 |
Cash From Financing Activities | 0.226 | 32.982 | 0.091 | 0.091 | 0.051 |
Issuance (Retirement) of Stock, Net | 0.458 | 32.982 | 0.091 | 0.091 | 0.051 |
Net Change in Cash | 12.238 | -40.615 | -61.059 | -75.053 | -62.669 |
Financing Cash Flow Items | -0.232 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Bio Therapeutic Drugs |
2929 Arch Street
Suite 600
PHILADELPHIA
PENNSYLVANIA 19104
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 580.000 多名交易者,選擇與 Capital.com 交易